Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency
This study is ongoing, but not recruiting participants.
Sponsor:
CSL Limited
Information provided by (Responsible Party):
CSL Limited
ClinicalTrials.gov Identifier:
NCT00680446
First received: May 16, 2008
Last updated: March 11, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |